The last "Milk Meeting" of the academic year featured a trio of talented Ph.D. student presentations from Nicholas Bokulich, Jincui Huang, and Zachery Lewis.
Revisit the exciting research, the multi-disciplinary collaborations, the substantial grants and awards, the outstanding student publications, and a year of special events from the Foods for Health Institute. We have accomplished some incredible things in 2012; here are some important events that shaped the Institute and opened new possibilities for the future.
With a $9.3 million startup grant from the National Institutes of Health, UC Davis has opened the West Coast Metabolomics Center, a high-tech consortium of research laboratories that will help scientists better understand and develop more effective treatments for complex diseases like diabetes, atherosclerosis and cancer.
This June, the UC Davis Foods for Health Institute and the USDA Western Human Nutrition Research Center jointly hosted the phenotyping conference, "measuring response to food: phenotyping tools and targets."
The Foods for Health Institute is proud to present the third in a series of seminars about the frontiers of interdisciplinary biosciences, featuring the work of Dr. Malin Nording on May 11.
Metabolic Phenotype Program researchers at the Foods for Health Institute received a substantial grant from the Dairy Research Institute to explore the metabolic effects of consuming different types of dairy product fats compared to non-dairy products containing similar fats.
FFHI faculty member Dr. Peter Havel and his research group have been studying the specific effects of eating sugar in its various forms for nearly 15 years. Their work was recently highlighted in a New York Times Magazine article and this month 60 Minutes was at UCD and UCD Health System for three days filming their current clinical study for an in-depth feature on sugar.
Foods for Health Institute researcher Carolyn Slupsky uses metabolomics, a powerful technique that measures multiple metabolites simultaneously, to discover novel biomarkers of disease, monitor effectiveness of treatments, and assess health status in a variety of health conditions. Her latest work focuses on detecting changes in the composition of intestinal microbiota and the effects of these changes on the health of individuals.